Hirsutism Evaluation Panel
2001763
Ordering Recommendation
Aids in the detection and subclassification of hyperandrogenism. Most useful in women and children with moderate/severe hirsutism or hirsutism of any degree when it is sudden in onset or rapidly progressive.
Mnemonic
HIRSUTISM
Methodology
Quantitative Chemiluminescent Immunoassay/Electrochemiluminescent Immunoassay/Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun, Tue-Fri
Reported
1-4 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
Collect between 6-10 a.m.  
Collect
Serum separator tube.  
Specimen Preparation
Separate serum from cells ASAP or within 2 hours of collection. Transfer 2.5 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 1.5 mL)  
Storage/Transport Temperature
Frozen.  
Unacceptable Conditions
Hemolyzed specimens.  
Remarks
  
Stability
After separation from cells: Ambient: 2 hours; Refrigerated: 48 hours; Frozen: 2 months  
Reference Interval
 
 
Test Number Components Reference Interval
2001638Androstenedione Effective August 19, 2013
 
Age Female Male
Premature Infants, 26-​28 weeks-​Day 4 0.92-​2.82 ng/mL 0.92-​2.82 ng/mL
Premature Infants, 31-​35 weeks-​Day 4 0.80-​4.46 ng/mL 0.80-​4.46 ng/mL
Full-​term Infants, 1-​7 days 0.20-​2.90 ng/mL 0.20-​2.90 ng/mL
8-​30 days 0.18-​0.80 ng/mL 0.18-​0.80 ng/mL
1-​5 months 0.06-​0.68 ng/mL 0.06-​0.68 ng/mL
6-​24 months Less than 0.15 ng/mL 0.03-​0.15 ng/mL
2-​3 years Less than 0.16 ng/mL Less than 0.11 ng/mL
4-​5 years 0.02-​0.21 ng/mL 0.02-​0.17 ng/mL
6-​7 years 0.02-​0.28 ng/mL 0.01-​0.29 ng/mL
8-​9 years 0.04-​0.42 ng/mL 0.03-​0.30 ng/mL
10-​11 years 0.09-​1.23 ng/mL 0.07-​0.39 ng/mL
12-​13 years 0.24-​1.73 ng/mL 0.10-​0.64 ng/mL
14-​15 years 0.39-​2.00 ng/mL 0.18-​0.94 ng/mL
16-​17 years 0.35-​2.12 ng/mL 0.30-​1.13 ng/mL
18-​39 years 0.26-​2.14 ng/mL 0.33-​1.34 ng/mL
40 years and older 0.13-​0.82 ng/mL 0.23-​0.89 ng/mL
Pre-​menopausal 0.26-​2.14 ng/mL Does Not Apply
Postmenopausal 0.13-​0.82 ng/mL Does Not Apply
Tanner Stage I 0.05-​0.51 ng/mL 0.04-​0.32 ng/mL
Tanner Stage II 0.15-​1.37 ng/mL 0.08-​0.48 ng/mL
Tanner Stage III 0.37-​2.24 ng/mL 0.14-​0.87 ng/mL
Tanner Stage IV-​V 0.35-​2.05 ng/mL 0.27-​1.07 ng/mL
0070040Dehydroepiandrosterone Sulfate, Serum  
 
Age Male Female
0-​6 days
7-​30 days
1-​5 months
6-​35 months
3-​6 years
7-​9 years
10-​14 years
15-​19 years
20-​29 years
30-​39 years
40-​49 years
50-​59 years
60-​69 years
70 years and older
108-​607 µg/dL
32-​431 µg/dL
3-​124 µg/dL
0-​33 µg/dL
0-​44 µg/dL
5-​115 µg/dL
22-​332 µg/dL
88-​483 µg/dL
280-​640 µg/dL
120-​520 µg/dL
95-​530 µg/dL
70-​310 µg/dL
42-​290 µg/dL
28-​175 µg/dL
108-​607 µg/dL
32-​431 µg/dL
3-​124 µg/dL
0-​29 µg/dL
0-​47 µg/dL
5-​94 µg/dL
22-​255 µg/dL
63-​373 µg/dL
65-​380 µg/dL
45-​270 µg/dL
32-​240 µg/dL
26-​200 µg/dL
13-​130 µg/dL
10-​90 µg/dL
Tanner Stage I
Tanner Stage II
Tanner Stage III
Tanner Stage IV & V
7-​209 µg/dL
28-​260 µg/dL
39-​390 µg/dL
81-​488 µg/dL
7-​126 µg/dL
13-​241 µg/dL
32-​446 µg/dL
65-​371 µg/dL
0081059Testosterone Free, Females or Children  
 
Female Free Testosterone, pg/mL Male Free Testosterone, pg/mL
1-​6 years: Less than 0.6 pg/mL
7-​9 years: 0.6-​1.8 pg/mL
10-​11 years: 0.1-​3.5 pg/mL
12-​13 years: 0.9-​6.8 pg/mL
14-​15 years: 1.2-​7.5 pg/mL
16-​17 years: 1.2-​9.9 pg/mL
18-​30 years: 0.8-​7.4 pg/mL
31-​40 years: 1.3-​9.2 pg/mL
41-​51 years: 1.1-​5.8 pg/mL
Postmenopausal: 0.6-​3.8 pg/mL
Tanner Stage I: Less than 2.2 pg/mL
Tanner Stage II: 0.4-​4.5 pg/mL
Tanner Stage III: 1.3-​7.5 pg mL
Tanner Stage IV: 1.1-​15.5 pg/mL
Tanner Stage V: 0.8-​9.2 pg/mL
1-​6 years: Less than 0.6 pg/mL
7-​9 years: 0.1-​0.9 pg/mL
10-​11 years: 0.1-​6.3 pg/mL
12-​13 years: 0.5-​98.0 pg/mL
14-​15 years: 3-​138.0 pg/mL
16-​17 years: 38.0-​173.0 pg/mL
18 years and older: 47-​244 pg/mL
Tanner Stage I: Less than or equal to 3.7 pg/mL
Tanner Stage II: 0.3-​21 pg/mL
Tanner Stage III: 1.0-​98.0 pg mL
Tanner Stage IV: 35.0-​169.0 pg/mL
Tanner Stage V: 41.0-​239.0 pg/mL
0081058Testosterone, Females or Children Effective August 19, 2013
 
Age Female Male
Premature (26-​28 weeks) 5-​16 ng/dL 59-​125 ng/dL
Premature (31-​35 weeks) 5-​22 ng/dL 37-​198 ng/dL
Newborn 20-​64 ng/dL 75-​400 ng/dL
1-​5 months Less than 20 ng/dL 14-​363 ng/dL
6-​24 months Less than 9 ng/dL Less than 37 ng/dL
2-​3 years Less than 20 ng/dL Less than 15 ng/dL
4-​5 years Less than 30 ng/dL Less than 19 ng/dL
6-​7 years Less than 7 ng/dL Less than 13 ng/dL
8-​9 years 1-​11ng/dL 2-​8 ng/dL
10-​11 years 3-​32 ng/dL 2-​165 ng/dL
12-​13 years 6-​50 ng/dL 3-​619 ng/dL
14-​15 years 6-​52 ng/dL 31-​733 ng/dL
16-​17 years 9-​58 ng/dL 158-​826 ng/dL
18-​39 years 9-​55 ng/dL 300-​1080 ng/dL
40-​59 years 9-​55 ng/dL 300-​890 ng/dL
60 years and older 5-​32 ng/dL 300-​720 ng/dL
Premenopausal (Greater than 18 years) 9-​55 ng/dL Does Not Apply
Postmenopausal 5-​32 ng/dL Does Not Apply
Tanner Stage I 2-​17 ng/dL 2-​15 ng/dL
Tanner Stage II 5-​40 ng/dL 3-​303 ng/dL
Tanner Stage III 10-​63 ng/dL 10-​851 ng/dL
Tanner Stage IV-​V 11-​62 ng/dL 162-​847 ng/dL
0099375Sex Hormone Binding Globulin
 
Age Male Female
1-​30 days
31-​364 days
1-​3 years
4-​6 years
7-​9 years
10-​12 years
13-​15 years
16-​17 years
18 years and older
13-​85 nmol/L
70-​250 nmol/L
50-​180 nmol/L
45-​175 nmol/L
28-​190 nmol/L
23-​160 nmol/L
13-​140 nmol/L
10-​60 nmol/L
11-​80 nmol/L
14-​60 nmol/L
60-​215 nmol/L
60-​190 nmol/L
55-​170 nmol/L
35-​170 nmol/L
17-​155 nmol/L
11-​120 nmol/L
19-​145 nmol/L
30-​135 nmol/L
Tanner Stage I
Tanner Stage II
Tanner Stage III
Tanner Stage IV
Tanner Stage V
26-​186 nmol/L
22-​169 nmol/L
13-​104 nmol/L
11-​60 nmol/L
11-​71 nmol/L
30-​173 nmol/L
16-​127 nmol/L
12-​98 nmol/L
14-​151 nmol/L
23-​165 nmol/L
Interpretive Data


See Compliance Statement B: www.aruplab.com/CS  
Note
 
CPT Code(s)
82157; 82627; 84403; 84270
Components
Component Test Code*Component Chart Name
0070040DHEAS
0081058Testosterone, LC-MS/MS
0081096Testosterone, Free LC-MS/MS
0099375Sex Hormone Binding Globulin
2001639Androstenedione by TMS
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases